A legal entity establishing and managing a repository used to verify the authenticity of or decommission the unique identifiers of medicinal products placed on the market in a Member State shall grant access to that repository and to the information contained therein, to competent authorities of that Member State for the following purposes:

1. (a)

   supervising the functioning of the repositories and investigating potential incidents of falsification;

2. (b)

   reimbursement;

3. (c)

   pharmacovigilance or pharmacoepidemiology.